Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.89NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.315NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.315NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.204NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.204NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21309.6South Korea
B.1.177.50NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.50NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.170NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.170NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.232NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.232NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.84NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.84NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.521NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.521NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.383NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.383NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.117NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.117NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.157NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.157NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.187NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.187NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.389NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.389NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.549NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.549NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.43.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.43.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
V.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
V.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.149NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.149NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.413NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.413NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.9.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used